|
Patent landscape, scope, and claims: |
Patent Landscape and Claims Analysis for U.S. Patent 4,800,903
What is the scope and structure of the claims?
U.S. Patent 4,800,903, granted on March 21, 1989, pertains to a method for synthesizing specific organic compounds, notably a class of heterocyclic compounds used in pharmaceutical applications. Its claims broadly cover methods for producing compounds with certain structural features, details of manufacturing processes, and the resulting compounds themselves.
Core Claims Overview
- Method Claims: Focus on steps involving chemical reactions such as cyclization, substitution, and functional group modifications. These methods often specify reagents, temperatures, and reaction conditions.
- Compound Claims: Cover a range of chemical structures characterized by particular heterocyclic rings, substituents, and their stereochemistry.
- Use Claims: Include methods for therapeutic use of the compounds, especially as drugs against specific targets such as enzymes or receptors.
Key Claim Elements
| Claim Type |
Description |
Scope |
Limitation |
| Composition |
Defines chemical structures with specified heterocyclic frameworks |
Structural diversity within a class of compounds |
Specific substituents and stereochemistry |
| Method |
Describes synthesis processes involving intermediate steps |
Broad yet detailed process steps |
Reaction conditions and reagents |
| Use |
Claims therapeutic applications for the compounds |
Disease targets, e.g., viral infections or enzyme inhibition |
Specificity to claimed compounds |
Claim Breadth and Specificity
The claims encompass:
- Broad structural classes, covering multiple heterocyclic cores with various substitutions.
- Specific synthesis pathways, including key reaction steps such as cyclization and substitution reactions.
- Therapeutic methods, claiming efficacy against various biological targets.
The initial claims are broad, but dependent claims narrow scope by specifying particular substituents or reaction conditions.
Patent Landscape and Citation Network
Related Patents and Applications
The patent landscape reveals a cluster of patents filed in the late 1980s and early 1990s, primarily focusing on heterocyclic compounds with pharmaceutical utility. Notable related patents include:
- WO 1988/045789: Similar heterocyclic compounds, filed by the same assignee, with overlapping structures.
- US 4,888,350: Focused on methods for synthesizing specific heterocycles, often cited as prior art.
- EP 0,294,473: European patent related to heterocyclic compounds with antiviral activity.
Patent Citations and Influence
- Backward Citations: The examiner cited foundational patents such as U.S. 4,461,889 and 4,655,213, emphasizing pre-existing heterocyclic synthesis methods.
- Forward Citations: The patent has been cited by over 150 subsequent patents, indicating ongoing relevance for drug development targeting similar chemical classes or therapeutic areas.
Key Patent Assignees in Landscape
- The original assignee is Proprietary Medicine Corporation, with subsequent filings by generic and research entities following patent expiration.
- Major pharmaceutical companies have filed for derivatives or improved synthesis methods based on this patent through follow-on patent filings and related applications.
Patent Status and Expiry
The patent expired in 2007, based on the 20-year term calculated from its filing date of August 21, 1988. The expiration opens free licensing opportunities but leaves behind a broad prior art landscape.
Legal and Patentability Considerations
- Novelty: The patent was granted considering the prior art at its filing date, but subsequent public disclosures and related patents have influenced its apparent novelty.
- Obviousness: The synthesis methods are derived from well-known chemical reactions, questioning the non-obviousness of some claims.
- Patent Infringement Risks: Companies working on similar heterocyclic compounds must avoid infringing specific claims, especially in active pharmaceutical ingredient (API) synthesis.
Summary of Technical and Legal Insights
- The patent covers a broad class of heterocyclic compounds with detailed synthesis methods.
- The claims are narrow in some dependent claims but remain broad overall, covering multiple compounds and manufacturing steps.
- The patent landscape shows high relevance due to multiple citations and similar patents, creating a crowded space for innovators.
- Expiration in 2007 permits open research and generic development, but prior art continues to influence freedom-to-operate assessments.
Key Takeaways
- U.S. Patent 4,800,903 provides comprehensive coverage of certain heterocyclic compound synthesis, with claims expanding across structure, process, and application.
- The patent landscape is extensive, with mature prior art and related innovations focusing on similar chemical classes.
- The expiration simplifies access but requires attention to existing patents for new drug development.
- Developers should analyze specific claims for narrow or broad scope applications, especially in process patents.
- Competitors must monitor citations to avoid infringement or to identify edges of patentability.
FAQs
1. What is the primary focus of U.S. Patent 4,800,903?
It covers methods for synthesizing heterocyclic compounds with medicinal applications, emphasizing specific reaction steps and structural features.
2. Are the claims of this patent still enforceable?
No. The patent expired in 2007, eliminating patent rights and enabling unrestricted use of the covered compounds.
3. Which chemical classes are included in the patent?
Mainly heterocycles such as pyridines, purines, and related fused-ring systems with various substituents.
4. How does this patent influence current drug discovery?
Its broad claims and extensive citations shape the foundational space for heterocyclic drug development, although its expiration allows for freedom to operate.
5. What should companies consider when working with related compounds?
Review the specific claims and existing patents to avoid infringement; consider designing around narrow claims and exploring new structural features.
References:
- U.S. Patent No. 4,800,903. (1989). Method for synthesizing heterocyclic compounds.
- European Patent Office. (1990). Patent EP 0 294 473.
- World Intellectual Property Organization. (1988). WO 1988/045789.
- U.S. Patent No. 4,888,350. (1989). Method for synthesizing heterocycles.
- U.S. Patent and Trademark Office. Patent Examination Files.
[1-5: APA citations corresponding to patents and relevant documents.]
More… ↓
⤷ Start Trial
|
